Insulin startup Thermalin gets JDRF support for an ultra rapid-acting insulin for T1D

Featured Story

Insulin startup Thermalin gets JDRF support for an ultra rapid-acting insulin for T1D

April 23, 2014 9:00 am by | 1 Comments

Insulin startup Thermalin Diabetes has earned itself an esteemed new partner in its quest to develop formulations of insulin that will give people with diabetes tighter control over their blood…


Benefits of aspirin for colorectal cancer prevention comes down to personalized medicine

Benefits of aspirin for colorectal cancer prevention comes down to personalized medicine

April 24, 2014 5:00 am by | 0 Comments

(Reuters) Cancer is the first disease where physicians have personalized treatment, matching a tumor’s genetics to the appropriate chemotherapy, and now it may be the first in which prevention, too,…


Drug resistant TB treatment backed by Gates Foundation poised for late-stage testing

Drug resistant TB treatment backed by Gates Foundation poised for late-stage testing

April 23, 2014 4:26 pm by | 0 Comments

(Reuters) The first experimental drug that fights both conventional and drug-resistant forms of tuberculosis is advancing to late-stage clinical testing, researchers said on Wednesday, raising hope for a new way…



Entrepreneurs: VCs want to see (now more than ever) that you’re a good money manager

Entrepreneurs: VCs want to see (now more than ever) that you’re a good money manager

April 23, 2014 1:07 pm by | 1 Comments

A financial investor, two venture capitalists and a corporate venture investor had different perspectives but all agreed on one thing at the MidAmerica Healthcare Venture Forum on Tuesday – the…


Can Pfizer build a better psoriasis treatment with rheumatoid arthritis drug?

Can Pfizer build a better psoriasis treatment with rheumatoid arthritis drug?

April 23, 2014 8:00 am by | 0 Comments

Pfizer Inc. announced Tuesday that a drug discovered and developed at its Groton laboratories has proven effective enough against plaque psoriasis that it plans to formally request regulatory approval for…


Frenzy of pharma deals resembles 2008, but goal is leaner, more focused businesses

Frenzy of pharma deals resembles 2008, but goal is leaner, more focused businesses

April 23, 2014 7:01 am by | 0 Comments

Between Pfizer and AstraZeneca deal rumors followed by a strategic portfolio exchange by GlaxoSmithKline and Novartis and an offer for Allergan this week, it feels like a deal frenzy is…


Allergan said it will ‘carefully consider’ buyout offer from Valeant

Allergan said it will ‘carefully consider’ buyout offer from Valeant

April 22, 2014 9:00 pm by | 0 Comments

Allergan Inc., the Irvine company that makes popular wrinkle treatment Botox, acknowledged Tuesday that it has received a buyout offer from Valeant Pharmaceuticals International Inc. The company said the offer…


Maker of Botox wrinkle treatment attracts $45.6B bid from activist investor Ackman and Valeant Pharma

Maker of Botox wrinkle treatment attracts $45.6B bid from activist investor Ackman and Valeant Pharma

April 22, 2014 12:26 pm by | 0 Comments

Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle…



With multilayered deal, GSK and Novartis play to their strengths

With multilayered deal, GSK and Novartis play to their strengths

April 22, 2014 11:23 am by | 0 Comments

Update below It’s all change with Big Pharma this week. A series of deals between GlaxoSmithKline (NYSE: GSK) and Novartis has reshaped both businesses in a move that will shift…


ProNAi raises $60 million to advance treatment to combat lymphoma

ProNAi raises $60 million to advance treatment to combat lymphoma

April 21, 2014 6:16 pm by | 0 Comments

Cancer drug developer ProNAi Therapeutics, which developed a nucleic acid-based DNA-interference technology to cause cancer cell death, has added nine new investors in an oversubscribed Series D round. The latest…


Building a new product for doctors? An MD/VC has some advice for winning over early adopters

Building a new product for doctors? An MD/VC has some advice for winning over early adopters

April 21, 2014 12:02 pm by | 0 Comments

Dr. Akhil Saklecha has seen many a startup stumble over the process of getting physician adoption of new technology. If a company fails to get physicians on board early in…


Amidst Gilead’s Hepatitis C pill patent debate in India, concerns about access to breakthrough drug

Amidst Gilead’s Hepatitis C pill patent debate in India, concerns about access to breakthrough drug

April 21, 2014 10:42 am by | 0 Comments

A cure for hepatitis C might seem like welcome news in India, where 12 million people suffer from the disease. But the country isn’t quite rolling out the red carpet…


Here are five different approaches to crowdfunding for biotechnology

Here are five different approaches to crowdfunding for biotechnology

April 21, 2014 8:19 am by | 1 Comments

The impact of federal budget cuts compounded by the challenges of securing funding for biotechnology companies has led to a growing trend of drug development. Scientists are turning to crowdfunding…


Four old meds leading the price spike among generics: doxycycline, albuterol, clomipramine, and captopril

Four old meds leading the price spike among generics: doxycycline, albuterol, clomipramine, and captopril

April 21, 2014 4:00 am by | 0 Comments

Pharmacist Larry Cowan can flip through his records and spot the generic drugs that have taken big price jumps in the past year or so.
There’s digoxin, a heart medicine that he used to buy for pennies a pill.
“Now the price is close to 10 times that,” …


Too many children’s emergency room visits result in codeine prescriptions

Too many children’s emergency room visits result in codeine prescriptions

April 21, 2014 12:38 am by | 0 Comments

CHICAGO (AP) — Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a…


Google hires UCSF geneticist who figured out how to stop aging in roundworms

Google hires UCSF geneticist who figured out how to stop aging in roundworms

April 20, 2014 5:22 am by | 0 Comments

Google’s mysterious health venture dedicated to extending human life has quietly lured a prominent scientist away from UCSF, The Chronicle has learned.
The university confirmed that Cynthia Kenyon, a biochemistry and biophysics professor acclaimed for …